natriuretic peptide receptor 1/2 agonists (Novartis)

N/A

Report date: 2025/06/11 10:38:41
NME

Base Information

Drug Namenatriuretic peptide receptor 1/2 agonists (Novartis)
Drug Alias Namedual NPR1/NPR2 agonists (Novartis)NP-13
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionNatriuretic peptide receptor 1 agonistsAtrial natriuretic peptide receptor type B agonists
TargetsNatriuretic peptide receptor 1Atrial natriuretic peptide receptor type B
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Ag
Inactive CompaniesN/A
Active IndicationsGlaucoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A